Molecular surveillance of influenza A and B in namibia: seasonal patterns and clinical correlates (2021–2023)

Influenza viruses cause widespread respiratory illness. Due to limited surveillance, influenza dynamics in Namibia remain poorly understood. This study aimed to conduct molecular surveillance of influenza A and B viruses from 2021 − 2023, characterize circulating strains, and explore symptom correlations to inform public health responses and improve case management. From October 2021 to December 2023, nasopharyngeal or oropharyngeal swabs were collected from patients with influenza-like illness (ILI) in a clinic-based setting. Viral detection, subtyping, and genotyping were conducted using real-time reverse-transcription polymerase chain reaction (RT-PCR). Seasonal trends of influenza and SARS-CoV-2, as well as symptom co-occurrence patterns were examined using statistical and visualization tools in R, Epi Info, and SPSS. A total of 1186 nasopharyngeal and oropharyngeal samples form ILI patients were collected. Influenza was detected in 25.7% (280/1088) of samples, with influenza A accounting for 20.2% (235/1162) and influenza B for 4.3% (45/1049). Among influenza A cases, A(H1N1)pdm09 was detected in 26.4% (62/235) and A(H3N2) in 67% (157/235). Influenza B (Victoria) accounted for nearly all influenza B cases (96%), while no influenza B(Yamagata) cases were detected. SARS-CoV-2 was detected in 19.2% (227/1182) of samples. Significant associations were observed between influenza infection and cough (OR 2.2, 95% CI 1.2 − 3.9, p = 0.0076) and myalgia (OR 2.3, 95% CI 1.5 − 3.6, p = 0.00044). The strongest correlation was between loss of smell and loss of taste (r = 0.71, p < 0.001). Influenza activity followed distinct seasonal patterns, with influenza A more common than B. Cough and myalgia were stronger predictors of infection, while sore throat and loss of smell were less so. These findings highlight the importance of ongoing influenza surveillance and preparedness to manage seasonal outbreaks, while symptom correlations can enhance case management and monitoring.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2025-10-14
DOI
https://doi.org/10.1186/s12879-025-11554-6
Citations
2
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular surveillance of influenza A and B in namibia: seasonal patterns and clinical correlates (2021–2023)

Kapena Tjombonde, Harris Onywera, Paulina N. Naupu, Andreas Shiningavamwe et al.
2 citations
BMC Infectious Diseases
Influenza Virus Research Studies
2.71
article

Molecular surveillance of influenza A and B in namibia: seasonal patterns and clinical correlates (2021–2023)

Kapena Tjombonde, Harris Onywera, Paulina N. Naupu, Andreas Shiningavamwe, Iyaloo N. Konstantinus, Nathalia Garus-oas, Ndahafa Frans, Cara M. Dunaiski
article en
2 citations

Abstract

Influenza viruses cause widespread respiratory illness. Due to limited surveillance, influenza dynamics in Namibia remain poorly understood. This study aimed to conduct molecular surveillance of influenza A and B viruses from 2021 − 2023, characterize circulating strains, and explore symptom correlations to inform public health responses and improve case management. From October 2021 to December 2023, nasopharyngeal or oropharyngeal swabs were collected from patients with influenza-like illness (ILI) in a clinic-based setting. Viral detection, subtyping, and genotyping were conducted using real-time reverse-transcription polymerase chain reaction (RT-PCR). Seasonal trends of influenza and SARS-CoV-2, as well as symptom co-occurrence patterns were examined using statistical and visualization tools in R, Epi Info, and SPSS. A total of 1186 nasopharyngeal and oropharyngeal samples form ILI patients were collected. Influenza was detected in 25.7% (280/1088) of samples, with influenza A accounting for 20.2% (235/1162) and influenza B for 4.3% (45/1049). Among influenza A cases, A(H1N1)pdm09 was detected in 26.4% (62/235) and A(H3N2) in 67% (157/235). Influenza B (Victoria) accounted for nearly all influenza B cases (96%), while no influenza B(Yamagata) cases were detected. SARS-CoV-2 was detected in 19.2% (227/1182) of samples. Significant associations were observed between influenza infection and cough (OR 2.2, 95% CI 1.2 − 3.9, p = 0.0076) and myalgia (OR 2.3, 95% CI 1.5 − 3.6, p = 0.00044). The strongest correlation was between loss of smell and loss of taste (r = 0.71, p < 0.001). Influenza activity followed distinct seasonal patterns, with influenza A more common than B. Cough and myalgia were stronger predictors of infection, while sore throat and loss of smell were less so. These findings highlight the importance of ongoing influenza surveillance and preparedness to manage seasonal outbreaks, while symptom correlations can enhance case management and monitoring.

BMC Infectious DiseasesVol. 25(1)
University of Cape Town (ZA), Africa Centres for Disease Control and Prevention (ET), Namibia Institute of Pathology (NA)
Openalex Percentile: Top 8%
Influenza Virus Research Studies
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.